Sanus provides an opportunity to monetize medical data. A significant fraction of medical spending aimed at diagnosis or response to therapy produces medical data. Typically, this information is only used once, at the time when the medical decision is made for or by the patient. But these medical insights from this medical experience, namely biomarkers that are measured by clinical diagnostics and response to therapy more importantly hold future value to patients with similar conditions. This means that a significant fraction of the $4.5T in annual healthcare spending by the US can be reutilized. This number suggests the scalability and sustainability of the Sanus business model of sharing and reusing medical data.

Investors in the early stages of our growth can reap tremendous financial rewards and invest in a mechanism that is resistant to inflation and distress of currency, because healthcare revenue unlocks the potential to create what the world needs in addition to precision medicine — a sustainable and objective currency tied to utilization, with a reliable store of value, liquidity transfers (of information) and independence and transparency of rules governing the creation and use of digital collateral and equity.